LSE:AZN (AstraZeneca PLC)

About AZN

AstraZeneca is a biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Respiratory, Inflammation and Autoimmunity (RIA), Cardiovascular and Metabolic Disease (CVMD) and Oncology – as well as in Infection and Neuroscience.

AstraZeneca PLC (LSE: AZN) Latest News

BUY AND HOLD spelled in letters on top of a pile of books. Alongside is a piggy bank in glasses. Buy and hold is a popular long term stock and shares strategy.
Investing Articles

This is how many FTSE 100 shares I’d likely need for £1,000 a month in passive income

I think dividend shares are a great way to build a passive income stream. I'm wondering how many I'd need…

Read more »

Hand flipping wooden cubes for change wording" Panic" to " Calm".
Investing Articles

What does the UK recession mean for FTSE 100 stocks?

Following news that the UK economy fell into recession at the end of 2023, Charlie Carman considers what could be…

Read more »

Engineer Project Manager Talks With Scientist working on Computer
Investing Articles

FTSE 100 earnings: why did the AstraZeneca share price fall 7%?

Our writer considers the reasons for AstraZeneca's fall in the FTSE 100 today and explains why he isn't too worried…

Read more »

Female Doctor In White Coat Having Meeting With Woman Patient In Office
Investing Articles

As the AstraZeneca share price dips on results day, I ask if the stock is too high

Earnings are up in 2023, but the AstraZeneca share price just fell. Is the love affair with the Covid vaccine…

Read more »

Young Caucasian girl showing and pointing up with fingers number three against yellow background
Investing Articles

3 top FTSE 100 stocks that easily pass the ‘snap test’

Our writer takes a look at a trio of FTSE 100 stocks that would be sorely missed if they vanished…

Read more »

One English pound placed on a graph to represent an economic down turn
Investing Articles

£7,000 to invest? I’d consider these stocks in the FTSE 100 right now

Like a resurgent Rolls-Royce, multiple FTSE 100 businesses can sometimes deliver decent returns for investors over a reasonable timescale.

Read more »

Businessman use electronic pen writing rising colorful graph from 2023 to 2024 year of business planning and stock investment growth concept.
Investing Articles

They outperformed the S&P 500 over 5 years! Are these the best UK shares to buy now?

Sure, the S&P 500 may deliver impressive returns, but I’m looking at three shares to buy here in the UK…

Read more »

Investing Articles

How I’d invest £20,000 in a Stocks and Shares ISA to target lifelong passive income

What should investors look for when investing in a Stocks and Shares ISA? Stephen Wright thinks the key for passive…

Read more »

Investor looking at stock graph on a tablet with their finger hovering over the Buy button
Investing Articles

Down more than 10% in 2023, Fools are backing these 5 UK stocks to reverse that – and then some! – in 2024

Five Fools see buying opportunities among these beaten-down shares in the UK stock markets!

Read more »

The Mall in Westminster, leading to Buckingham Palace
Investing Articles

If I had to buy just one FTSE 100 stock in 2024, it would be this

This Fool considered which FTSE 100 (INDEXFTSE:UKX) stock he’d buy next year if given only one choice. Here’s the champ…

Read more »

Concept of two young professional men looking at a screen in a technological data centre
Investing Articles

Are these 2 FTSE 100 companies recession-resistant?

Zaven Boyrazian explores two FTSE 100 giants that could outperform the stock market in the event of a near-term recession…

Read more »

Businessman use electronic pen writing rising colorful graph from 2023 to 2024 year of business planning and stock investment growth concept.
Investing Articles

Here’s a FTSE 100 giant I’m eyeing up for December!

This Fool explains why this FTSE 100 pharma giant is on her radar. She plans to snap up shares for…

Read more »